- Trials with a EudraCT protocol (17)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
17 result(s) found for: Gastrocnemius.
Displaying page 1 of 1.
EudraCT Number: 2016-005049-21 | Sponsor Protocol Number: MRZ-R-201212_01001_N_2 | Start Date*: 2017-01-12 |
Sponsor Name:LLC Merz Pharma, Russia | ||
Full Title: Multi-center Open Comparative Randomized Trial of Clinical and Neurophysiological Efficacy and Safety of Xeomin (Botulinum Toxin Type A) vs. Botox (Complex of Botulinum Toxin Type A and Hemaggluti... | ||
Medical condition: • Cerebral Palsy • Spastic Paraplegia and Hemiparesis • Equine and Equinovarus Foot Deformation | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2005-005197-78 | Sponsor Protocol Number: 1 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Queen's Medical Centre, Nottingham, University Hospital NHS Trust, | |||||||||||||
Full Title: A multi-centre, randomised, parallel group, cross-over study comparing the efficacy and safety of double versus multiple injections of Botulinum Toxin type-A (Dysport®), into the gastrocnemius musc... | |||||||||||||
Medical condition: Spasticity of the Gastrocnemius Muscle due to Cerebral Palsy | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004474-42 | Sponsor Protocol Number: V3_06082015 | Start Date*: 2015-05-07 | |||||||||||
Sponsor Name:Copenhagen University Hospital at Hvidovre | |||||||||||||
Full Title: Treatment of equinus gait caused by dynamic tightening of the calf muscles in children with cerebral palsy. A randomized, placebo controlled Botulinum toxin type A volume/response study. | |||||||||||||
Medical condition: Treatment of equinus gait caused by dynamic tightening of the calf muscles in children with cerebral palsy. | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004215-35 | Sponsor Protocol Number: TENPET | Start Date*: 2005-01-19 |
Sponsor Name:Turku PET Centre | ||
Full Title: Influence of muscle specific activation on regional glucose uptake in the human Achilles tendon | ||
Medical condition: The combined forces generated by the triceps surae muscles causes non-uniform strain within the human triceps aponeuroses. This may cause non-uniform tendon force that would result in intratendinou... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-004685-17 | Sponsor Protocol Number: ERA2005neuro | Start Date*: 2005-11-16 |
Sponsor Name:CUB - Hôpital Erasme | ||
Full Title: A prospective placebo controlled study of botulilium toxin (BOTOX) on gait disorder induced by spastic equinovarus foot. | ||
Medical condition: Spastic equinus foot is a common dynamic deformity in patients with cerebral palsy. This dynamic deformity, mainly caused by spasticity of the soleus, gastrocnemius and tibialis posterior muscles, ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005808-41 | Sponsor Protocol Number: EC 07/90601 | Start Date*: 2008-02-25 | |||||||||||
Sponsor Name:Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | |||||||||||||
Full Title: Estudio multicéntrico para comprobar la respuesta clínico-analítica de pacientes portadores sintomáticos de Disferlinopatía al tratamiento con Calcifediol Multicentric study to assess the clinica... | |||||||||||||
Medical condition: Portadores sintomaticos de una mutación en el gen disferlina. Symptomatic carriers of a mutation in the dysferlin gene | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000868-15 | Sponsor Protocol Number: PENT_PTA | Start Date*: 2012-03-06 | |||||||||||
Sponsor Name:UNIVERSITA' CAMPUS BIOMEDICO | |||||||||||||
Full Title: EFFECT OF TREATMENT WITH PENTOXIFYLLINE ABOUT THE RISK RATER OF POST-angioplasty restenosis IN PATIENTS WITH LOWER LIMB arterial disease | |||||||||||||
Medical condition: PERIPHERAL ARTERIOPATHY | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002539-32 | Sponsor Protocol Number: The_WE_Study | Start Date*: 2015-03-23 | |||||||||||
Sponsor Name:St. Olavs University Hospital | |||||||||||||
Full Title: The WE Study - Walking Easier with cerebral palsy | |||||||||||||
Medical condition: cerebral palsy | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) FR (Ongoing) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015868-34 | Sponsor Protocol Number: Y-55-52120-140 | Start Date*: 2011-02-15 | |||||||||||
Sponsor Name:Ipsen Pharma SAS | |||||||||||||
Full Title: A PHASE III, MULTICENTRE, DOUBLE BLIND, PROSPECTIVE, RANDOMISED, PLACEBO CONTROLLED STUDY, ASSESSING THE EFFICACY AND SAFETY OF DYSPORT USED FOR THE TREATMENT OF LOWER LIMB SPASTICITY IN ADULT SUBJ... | |||||||||||||
Medical condition: Leg Spasticity | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) SK (Completed) IT (Completed) PT (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005592-13 | Sponsor Protocol Number: FERRICHFII | Start Date*: 2014-02-27 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Mechanisms of Exercise Benefit with Intravenous Iron in Chronic Heart Failure: The Ferric Iron in Heart Failure (FERRIC HF) II Trial | |||||||||||||
Medical condition: Chronic Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000042-35 | Sponsor Protocol Number: 191622-111 | Start Date*: 2013-07-08 | ||||||||||||||||
Sponsor Name:Allergan Limited | ||||||||||||||||||
Full Title: BOTOX® Treatment in Pediatric Lower Limb Spasticity: Double-blind Study | ||||||||||||||||||
Medical condition: Lower Limb Spasticity | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) PL (Completed) HU (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-004608-32 | Sponsor Protocol Number: DYN101-C102 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Dynacure | |||||||||||||
Full Title: A Phase 1/2, multicenter, open-label, dose-confirmation trial to evaluate the safety and preliminary efficacy of DYN101 in subjects 2 to 17 years of age with centronuclear myopathy caused by mutati... | |||||||||||||
Medical condition: Centronuclear myopathy (CNM), in subjects 2 to 17 years of age (all ages inclusive)caused by mutations in the myotubularin1 (MTM1) or dynamin 2 (DNM2) gene | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017723-26 | Sponsor Protocol Number: Y5552120142 | Start Date*: 2011-04-28 | |||||||||||
Sponsor Name:Ipsen Pharma SAS | |||||||||||||
Full Title: A phase III, prospective, multicentre, open label, extension study, to assess the long term safety and efficacy of repeated treatment of Dysport® intramuscular injection in the treatment of lower l... | |||||||||||||
Medical condition: Leg Spasticity | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) SK (Completed) IT (Completed) PT (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005040-10 | Sponsor Protocol Number: PRO045-CLIN-01 | Start Date*: 2012-12-03 | |||||||||||
Sponsor Name:BioMarin Nederland B.V. | |||||||||||||
Full Title: A phase IIb, open-label study to assess the efficacy, safety, pharmacodynamics and pharmacokinetics of multiple subcutaneous doses of PRO045 in subjects with Duchenne muscular dystrophy | |||||||||||||
Medical condition: Duchenne muscular dystrophy resulting from a mutation correctable by PRO045-induced DMD exon 45 skipping | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) IT (Prematurely Ended) FR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005042-35 | Sponsor Protocol Number: PRO053-CLIN-01 | Start Date*: 2013-08-23 | |||||||||||
Sponsor Name:BioMarin Pharmaceutical Inc. | |||||||||||||
Full Title: A Phase I/II, open-label, dose escalating with 48 week treatment study to assess the safety and tolerability, pharmacokinetics, pharmacodynamics and efficacy of BMN 053 (previously known as PRO053)... | |||||||||||||
Medical condition: Duchenne muscular dystrophy resulting from a mutation correctable by BMN 053-induced DMD exon 53 skipping | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male | ||||||||||||
Trial protocol: GB (Prematurely Ended) BE (Completed) IT (Prematurely Ended) NL (Prematurely Ended) FR (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005421-40 | Sponsor Protocol Number: RCSI-1764 | Start Date*: 2016-06-14 | |||||||||||||||||||||||||||||||
Sponsor Name:Royal College of Surgeons in Ireland | |||||||||||||||||||||||||||||||||
Full Title: The use of topical Glyceryl Trinitrate (GTN) and eccentric exercises in the treatment of mid portion Achilles Tendinopathy: a randomised placebo controlled trial | |||||||||||||||||||||||||||||||||
Medical condition: Achilles tendinopathy | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: IE (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-019102-17 | Sponsor Protocol Number: Y-55-52120-147 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Ipsen Pharma SAS | |||||||||||||
Full Title: A PHASE III, PROSPECTIVE, MULTICENTRE, OPEN LABEL, EXTENSION STUDY ASSESSING THE LONG TERM SAFETY AND EFFICACY OF REPEATED TREATMENT WITH DYSPORT USED IN THE TREATMENT OF LOWER LIMB SPASTICITY IN C... | |||||||||||||
Medical condition: Lower limb spasticity in children with dynamic equinus foot deformity due to cerebral palsy | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
